Emory University Rhythm Pharmaceuticals, Inc. Transaction History

Emory University

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$19.53 - $25.5 $1.4 Million - $1.83 Million	-71,856 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$18.62 - $24.51 $267,234 - $351,767	-14,352 Reduced 16.65%	71,856 $1.55 Million
Q2 2019 Aug 14, 2019	BUY	$21.11 - $28.48 $143,759 - $193,948	6,810 Added 8.58%	86,208 $1.9 Million
Q1 2019 May 09, 2019	SELL	$24.76 - $31.66 $83,416 - $106,662	-3,369 Reduced 4.07%	79,398 $2.18 Million
Q4 2018 Feb 12, 2019	BUY	$24.11 - $31.34 $2 Million - $2.59 Million	82,767 New	82,767 $2.23 Million

179

68.7M

467K

224K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.57B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.